Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 5/20 | 1.00 |
| ▸ | MAOA | P21397 | 2/20 | 1.00 |
| ▸ | GABRP | O00591 | 4/20 | 0.62 |
| ▸ | GABRD | O14764 | 4/20 | 0.62 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.62 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.62 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.62 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.62 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.62 |
| ▸ | GABRA3 | P34903 | 4/20 | 0.62 |
| ▸ | GABRA2 | P47869 | 4/20 | 0.62 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.62 |
| ▸ | GABRA4 | P48169 | 4/20 | 0.62 |
| ▸ | GABRE | P78334 | 4/20 | 0.62 |
| ▸ | GABRA6 | Q16445 | 4/20 | 0.62 |
| ▸ | GABRG1 | Q8N1C3 | 4/20 | 0.62 |
| ▸ | GABRG3 | Q99928 | 4/20 | 0.62 |
| ▸ | GABRQ | Q9UN88 | 4/20 | 0.62 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24636395 | 0.85 | MAOB (0.74) | MAOBMAOAGABRPGABRDGABRA1 | |
| SCHEMBL1772762 | 0.81 | MAOB (1.00) | MAOBMAOAGABRPGABRDGABRA1 | |
| SCHEMBL29393270 | 0.81 | MAOB (0.77) | MAOBMAOAALOX5RAB9ANPC1 | |
| SCHEMBL731363 | 0.81 | MAOB (0.71) | MAOBMAOAGABRPGABRDGABRA1 | |
| SCHEMBL31105656 | 0.81 | MAOB (0.71) | MAOBMAOAGABRPGABRDGABRA1 | |
| SCHEMBL24871311 | 0.80 | MAOB (0.96) | MAOBMAOAGABRPGABRDGABRA1 | |
| SCHEMBL11647524 | 0.79 | MAOB (0.65) | MAOBMAOAGABRPGABRDGABRA1 | |
| SCHEMBL4111056 | 0.79 | MAOB (0.65) | MAOBMAOAALOX5RAB9ANPC1 | |
| SCHEMBL17336560 | 0.79 | MAOB (0.63) | MAOBMAOARAB9ANPC1TSHR | |
| SCHEMBL13140660 | 0.79 | MAOB (0.65) | MAOBMAOAALOX5RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12398316-B2 | Organic compound and organic electroluminescent device comprising same | DOOSAN SOLUS CO., LTD. (KR) | 2025-08-26 | — | — | US | disclosed |
| US-20230389347-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-11-30 | — | — | US | disclosed |
| US-20230389347-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-11-30 | — | — | US | disclosed |
| US-20200227650-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | DOOSAN CORPORATION (KR) | 2020-07-16 | — | — | US | disclosed |
| CN-110799499-A | Organic compound and organic electroluminescent element comprising same | 株式会社斗山 | 2020-02-14 | — | — | CN | disclosed |
| WO-2019004584-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 주식회사 두산 | 2019-01-03 | — | — | WO | disclosed |
| US-9461251-B2 | Anthracene derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-10-04 | — | — | US | disclosed |
| US-9461251-B2 | Anthracene derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-10-04 | — | — | US | disclosed |
| US-9461251-B2 | Anthracene derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-10-04 | — | — | US | disclosed |
| EP-2163550-B1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | IDEMITSU KOSAN CO (JP) | 2015-09-09 | — | — | EP | disclosed |
| WO-2015087094-A1 | NEW ARYLALKENYLPROPARGYLAMINE DERIVATIVES EXHIBITING NEUROPROTECTIVE ACTION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | SEMMELWEIS EGYETEM (HU) | 2015-06-18 | — | — | WO | disclosed |
| US-20130313538-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | SONY CORPORATION (JP) | 2013-11-28 | — | — | US | disclosed |
| US-8512875-B2 | Anthracene derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2013-08-20 | — | — | US | disclosed |
| US-8512875-B2 | Anthracene derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2013-08-20 | — | — | US | disclosed |
| US-8512875-B2 | Anthracene derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2013-08-20 | — | — | US | disclosed |
| EP-2163550-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Idemitsu Kosan Co., Ltd. (JP) | 2010-03-17 | — | — | EP | disclosed |
| EP-2163550-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Idemitsu Kosan Co., Ltd. (JP) | 2010-03-17 | — | — | EP | disclosed |
| US-20080315754-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-12-25 | — | — | US | disclosed |
| US-20080315754-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-12-25 | — | — | US | disclosed |
| US-20080315754-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200227650-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | OR10J3, ORAI2, OR51E2 | MAOB 591/4885MAOA 346/4885GABRP 4128/4885 |
| US-12398316-B2 | Organic compound and organic electroluminescent device comprising same | TRPM6, TRPC6, TRPV6 | MAOB 352/4885MAOA 380/4885GABRP 4471/4885 |
| US-20080315754-A1 | ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | APRT, ETFA, MLLT3 | MAOB 349/4885MAOA 97/4885GABRP 4498/4885 |
| US-20230389347-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | LEF1, L1CAM, RER1 | MAOB 1396/4885MAOA 1303/4885GABRP 4784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.